Subscription price for shares in the incentive program LTIP 2024

At the extraordinary general meeting on February 20, 2024, it was decided to introduce the LTIP 2024 incentive program for staff in Sweden within SyntheticMR AB (publ) (hereinafter referred to as “the Company”), as well as the opportunity to subscribe for warrants of series TO 2. Furthermore, it was decided about TO 3, meaning an opportunity for an employee in the USA to subscribe for warrants of series TO 3. LTIP 2024 offers employees in the Company the opportunity to subscribe for shares, with accompanying share rights, at market value in a directed issue. The subscription price for shares in the directed issue has been set to SEK 25.04 per share.

The subscription price for shares in the directed issue related to LTIP 2024 corresponds, in accordance with the decision, to the volume-weighted average price of the Company's share on the Spotlight Stock Market during the trading period from February 21, 2024, to February 27, 2024.

The subscription price for TO 2 and TO 3 will be published in a separate press release.

For further information, please contact Ulrik Harrysson, CEO of SyntheticMR AB (publ).

Phone: +46 70 529 29 87

E-mail: ulrik.harrysson@syntheticmr.com.

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB product SyMRI® delivers multiple contrast images and quantitative data from a single 6-minute scan to improve patient throughput and objective decision support for clinicians. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com.